- €51.84m
- €48.32m
- €4.54m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 5.32 | ||
| Price to Tang. Book | 5.66 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 11.41 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -41.31% | ||
| Return on Equity | -51.36% | ||
| Operating Margin | -92.47% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 1.5 | 2 | 2.94 | 3.91 | 4.54 | 8.6 | 15.85 | 21.07% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Bioretec Oy is a Finland-based medical device manufacturer company focusing on the development of strong, safe and reliable bioresorbable implants for pediatric and adult orthopedics. The Company operates as a developer, manufacturer and commercializer of innovative bioresorbable orthopedic implants and implant materials used for the treatment of bone and soft tissue injuries. Bioretec Oy’s existing Activa product portfolio consists of bioabsorbable biopolymer products that are alreadyavailable in the market for applications in pediatrics, trauma surgery as well as sports surgery. Bioretec Oy has one Germany-based subsidiary, BRI.Tech GmbH. The Company’s products are used all over the world.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- June 12th, 1998
- Public Since
- September 28th, 2021
- No. of Employees
- 47
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
OMX Nordic Exchange - Helsinki- Shares in Issue
- 24,566,474
- Address
- Yrittajankulma 5, TAMPERE, 33710
- Web
- https://bioretec.com/
- Phone
- +358 207789500
- Auditors
- Ernst & Young Oy
Upcoming Events for BRETEC
Similar to BRETEC
DETECTION TECHNOLOGY Oyj
OMX Nordic Exchange - Helsinki
Modulight Oyj
OMX Nordic Exchange - Helsinki
Nexstim Oyj
OMX Nordic Exchange - Helsinki
Optomed Oyj
OMX Nordic Exchange - Helsinki
Revenio Oyj
OMX Nordic Exchange - Helsinki
FAQ
As of Today at 19:35 UTC, shares in Bioretec Oy are trading at €2.11. This share price information is delayed by 15 minutes.
Shares in Bioretec Oy last closed at €2.11 and the price had moved by -20.38% over the past 365 days. In terms of relative price strength the Bioretec Oy share price has underperformed the FTSE Global All Cap Index by -22.37% over the past year.
The overall consensus recommendation for Bioretec Oy is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreBioretec Oy does not currently pay a dividend.
Bioretec Oy does not currently pay a dividend.
Bioretec Oy does not currently pay a dividend.
To buy shares in Bioretec Oy you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €2.11, shares in Bioretec Oy had a market capitalisation of €51.84m.
Here are the trading details for Bioretec Oy:
- Country of listing: Finland
- Exchange: HEX
- Ticker Symbol: BRETEC
Based on an overall assessment of its quality, value and momentum Bioretec Oy is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Bioretec Oy is €2.80. That is 32.7% above the last closing price of €2.11.
Analysts covering Bioretec Oy currently have a consensus Earnings Per Share (EPS) forecast of -€0.22 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bioretec Oy. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +5.36%.
As of the last closing price of €2.11, shares in Bioretec Oy were trading -12.82% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Bioretec Oy PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €2.11.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Bioretec Oy's management team is headed by:
- Simo Hietaniemi - CEO
- Risto Penttila - DSL